会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 24. 发明授权
    • Initiator system for self-curing plastic materials, its use, and bone cement compositions containing it
    • 用于自固化塑料材料的引发剂体系,其用途和含有它的骨水泥组合物
    • US07989519B2
    • 2011-08-02
    • US12254541
    • 2008-10-20
    • Sebastian VogtHubert Buchner
    • Sebastian VogtHubert Buchner
    • A61K6/083C09K3/00
    • A61L24/043A61L24/001A61L27/26A61L27/50A61L2430/02C08L33/12
    • An initiator system for self-curing plastic material comprises a) at least one salt of a dialklylbarbituric acid and/or an alkylcycloalkylbarbituric acid and/or alkylarylbarbituric acid and/or a cycloalkylarylbarbituric acid that is insoluble in methacrylate monomers; b) at least one heavy metal salt that is insoluble in methacrylate monomers; c) at least one halogenide ion donor that is insoluble in methacrylate monomers; and d) at least one acid that is soluble in methacrylate monomers. The initiator system can be used for the preparation of paste/paste, paste/powder, paste/liquid, powder/liquid, and liquid/liquid combinations for the production of medical plastic material and dental materials. Additionally, a bone cement composition containing the initiator system is described.
    • 用于自固化塑料材料的引发剂体系包括:a)不溶于甲基丙烯酸酯单体的至少一种二烷基巴比妥酸和/或烷基环烷基巴比妥酸和/或烷基芳基巴比妥酸和/或环烷基芳基巴比妥酸的盐; b)至少一种不溶于甲基丙烯酸酯单体的重金属盐; c)至少一种不溶于甲基丙烯酸酯单体的卤化物离子供体; 和d)至少一种可溶于甲基丙烯酸酯单体的酸。 引发剂系统可用于制备糊剂/糊剂,糊剂/粉末,糊剂/液体,粉末/液体和液体/液体组合,用于生产医用塑料材料和牙科材料。 此外,描述了含有引发剂体系的骨水泥组合物。
    • 27. 发明授权
    • Method for the antibiotic coating of bodies with interconnecting microcavities as well as coated bodies and their usage
    • 具有互连微腔以及涂层体的物体的抗生素涂层方法及其用途
    • US07358232B2
    • 2008-04-15
    • US10174682
    • 2002-06-19
    • Sebastian VogtMatthias SchnabelrauchKlaus-Dieter Kühn
    • Sebastian VogtMatthias SchnabelrauchKlaus-Dieter Kühn
    • A61K31/70C07H15/02
    • A61K9/0024
    • The invention relates to a method for the antibiotic coating of bodies with interconnecting microcavities as well as bodies coated this way and their usage. The invented method is characterized in that in the microcavities of non-metallic bodies an aqueous solution 1, which contains at least one easily water-soluble antibiotic component from the groups of the aminoglycoside antibiotics, the tetracycline antibiotics, the lincosamide antibiotics and the 4-quinolone antibiotics, and an aqueous solution 2, which contains at least one easily water-soluble amphiphilic component from the groups of the alkyl sulfates, alkyl sulfonates, alkylaryl sulfates, dialkylaryl sulfates, alkylaryl sulfonates, dialkylaryl sulfonates, cycloalkyl sulfates, cycloalkyl sulfonates, alkylcycloalkyl sulfates, are introduced, wherein between the introduction of solutions 1 and 2 the water is basically removed through vaporization and/or evaporation, and whereby from the components of solutions 1 and 2 in the microcavities a deposit is formed, which is sparingly soluble in water.
    • 本发明涉及一种用于具有互连微腔的物体的抗生素包被的方法以及这种方式涂覆的物体及其用途。 本发明的方法的特征在于,在非金属体的微腔中,含有来自氨基糖苷类抗生素组的至少一种容易水溶性抗生素成分的水溶液1,四环素抗生素,林可素类抗生素和4- 喹诺酮抗生素和水溶液2,其含有至少一种容易水溶性的两亲成分,分别为烷基硫酸盐,烷基磺酸盐,烷基芳基硫酸盐,二烷基芳基硫酸盐,烷基芳基磺酸盐,二烷基芳基磺酸盐,环烷基硫酸盐,环烷基磺酸盐,烷基环烷基 硫酸盐,其中在引入溶液1和2之间基本上通过蒸发和/或蒸发除去水,并且由此在微腔中的溶液1和2的组分中形成沉积物,其沉积物微溶于水 。
    • 28. 发明申请
    • Polymethylmethacrylate bone cement
    • 聚甲基丙烯酸甲酯骨水泥
    • US20060293407A1
    • 2006-12-28
    • US11447807
    • 2006-06-06
    • Klaus-Dieter KuhnSebastian Vogt
    • Klaus-Dieter KuhnSebastian Vogt
    • A61K6/08
    • A61L27/50A61L24/001A61L24/06A61L27/16A61L2430/02C08L33/12
    • A polymethylmethacrylate bone cement with a liquid monomer component and a solid component contains in the monomer liquid, for example, 0.001-1.00 mass percent of a dye or dye mixture that is insoluble or poorly soluble in methacrylic acid methylester and, for example, 0.001-2.00 mass percent of a synthetically produced, protein-free, hydrophobic, low molecular or oligomeric solubilizer for the dye or dye mixture. The solubilizer preferably is liquid or pasty at room temperature. The monomer liquid is translucent at room temperature. Preferably, 0.001-1.00 mass percent of a dye or dye mixture that is insoluble or poorly soluble in methacrylic acid methylester and, preferably, 0.001-2.00 mass percent of a synthetically produced, protein-free, hydrophobic, low molecular or oligomeric solubilizer that is liquid or pasty at room temperature are homogeneously dissolved in the polymethacrylate or polymethylacrylate of the powder component.
    • 具有液体单体组分和固体组分的聚甲基丙烯酸甲酯骨粘固剂在单体液体中含有例如0.001-1.00质量%的不溶于或难溶于甲基丙烯酸甲酯的染料或染料混合物,例如, 用于染料或染料混合物的合成产生的无蛋白质,疏水性,低分子或低聚增溶剂的2.00质量%。 增溶剂在室温下优选为液体或糊状。 单体液体在室温下是半透明的。 优选0.001〜1.00质量%的不溶于或难溶于甲基丙烯酸甲酯的染料或染料混合物,优选0.001-2.00质量%的合成产生的无蛋白质,疏水性,低分子或低聚物的增溶剂,其为 液体或糊状物均匀地溶解在粉末组分的聚甲基丙烯酸酯或聚甲基丙烯酸甲酯中。
    • 29. 发明申请
    • Flexible generation of digitally reconstructed radiographs
    • 灵活地生成数字重建的X光片
    • US20050238223A1
    • 2005-10-27
    • US10953342
    • 2004-09-29
    • Jens GuhringSebastian VogtAli Khamene
    • Jens GuhringSebastian VogtAli Khamene
    • G06K9/00G06K9/36G06T15/08
    • G06T15/08
    • A system and corresponding method for flexible generation of digitally reconstructed radiograph (DRR) images on a graphics processing unit (GPU) are provided, the system including a processor, an imaging adapter in signal communication with the processor for receiving volumetric data, an integration unit in signal communication with the processor for integrating the volumetric data into incremental line integrals, and a modeling unit in signal communication with the processor for modeling composite line integrals from the incremental line integrals; and the corresponding method including receiving three-dimensional (3D) volumetric data into a graphics pipeline, integrating the 3D volumetric data into incremental line integrals along a plurality of viewing rays, modeling composite line integrals from the incremental line integrals, and adding the incremental line integrals for each composite line integral to form pixels of the DRR image.
    • 提供了一种用于在图形处理单元(GPU)上灵活生成数字重建X射线照片(DRR)图像的系统和相应方法,该系统包括处理器,与处理器进行信号通信的成像适配器,用于接收体积数据,整合单元 与处理器的信号通信,用于将体积数据集成到增量线积分中,以及与处理器进行信号通信的建模单元,用于从增量线积分建模复合线积分; 以及相应的方法,包括将三维(3D)体积数据接收到图形管线中,将3D体积数据集成到沿着多个观察射线的增量线积分中,从增量线积分建模复合线积分,以及将增量线 每个复合线的积分积分以形成DRR图像的像素。
    • 30. 发明授权
    • Antibiotic(s) preparation with retarding active ingredient release
    • 具有延缓活性成分释放的抗生素制剂
    • US06913764B2
    • 2005-07-05
    • US10100839
    • 2002-03-19
    • Sebastian VogtMatthias SchnabelrauchKlaus-Dieter Kühn
    • Sebastian VogtMatthias SchnabelrauchKlaus-Dieter Kühn
    • A61K9/00A61K9/10A61K9/14A61K9/20A61K9/22A61K9/70A61K31/00A61K31/70A61K31/7036A61K31/726A61K45/06A61K45/08A61K47/02A61K47/14A61K47/16A61K47/20A61K47/24A61L27/54A61L31/16A61K2/02
    • A61K31/7036A61K9/0024A61K9/2013A61K31/00A61L27/54A61L2300/406A61L2300/602A61L2300/802
    • The present invention concerns an antibiotic/antibiotics preparation for resorbable and non-resorbable implants for human and veterinary medicine, for the treatment of local microbial infections in hard and soft tissue. The invented antibiotic/antibiotics preparation is a mixture consisting of at least one amphiphilic component of a representative of the alkyl sulfates, aryl sulfates, alkylaryl sulfates, cycloalkyl sulfates, alkylcycloalkyl sulfates, alkyl sulfamates, cycloalkyl sulfamates, alkylcycloalkyl sulfamates, aryl sulfamates, alkylaryl sulfamates, alkyl sulfonates, fatty acid-2-sulfonates, aryl sulfonates, alkylaryl sulfonates, cycloalkyl sulfonates, alkylcycloalkyl sulfonates, alkyl disulfates, cycloalkyl disulfates, alkyl disulfonates, cycloalkyl disulfonates, aryl disulfonates, alkylaryl disulfonates, aryl trisulfonates and alkylaryl trisulfonates as well as at least one antibiotic component from the group of aminoglycoside antibiotics, lincosamide antibiotics, 4-quinolone antibiotics and tetracycline antibiotics, and if need be at least one anhydrous organic auxiliary component and if need be at least one inorganic auxiliary component and if need be at least one biologically active component. The antibiotic/antibiotics preparation of the invention has a retarding active ingredient release.
    • 本发明涉及用于人和兽医药物的可再吸收和不可吸收植入物的抗生素/抗生素制剂,用于治疗硬组织和软组织中的局部微生物感染。 本发明的抗生素/抗生素制剂是由至少一种代表烷基硫酸盐,芳基硫酸盐,烷基芳基硫酸盐,环烷基硫酸盐,烷基环烷基硫酸盐,氨基磺酸烷基酯,环烷基磺酸盐,烷基环烷基氨基磺酸盐,芳基亚磺酸盐,烷基芳基亚磺酸盐 烷基磺酸盐,脂肪酸-2-磺酸盐,芳基磺酸盐,烷基芳基磺酸盐,环烷基磺酸盐,烷基环烷基磺酸盐,烷基二硫酸盐,环烷基二硫酸盐,烷基二磺酸盐,环烷基二磺酸盐,芳基二磺酸盐,烷基芳基二磺酸盐,芳基三磺酸盐和烷基芳基三磺酸盐以及 至少一种来自氨基糖苷类抗生素的抗生素成分,林可素类抗生素,4-喹诺酮类抗生素和四环素抗生素,如果需要至少一种无机有机辅助成分,如果需要至少一种无机辅助成分,如果需要至少一种 生物活性成分 ent。 本发明的抗生素/抗生素制剂具有缓释活性成分释放。